Summary GlobalData's clinical trial report, Hepatitis C Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis C clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

1. Hepatitis C Global Clinical Trials Review, H2, 2014
Hepatitis C Global Clinical Trials Review, H2, 2014
Summary
GlobalData's clinical trial report, Hepatitis C Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis C clinical trial scenario. This report
provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitment status as
per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the
sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. This report is built using data and information
sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five
national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
table Of Contents 2
list Of Tables 5
list Of Figures 6
introduction 7
hepatitis C 7
report Guidance 7
clinical Trials By Region 8
clinical Trials And Average Enrollment By Country 9
top Five Countries Contributing To Clinical Trials In Asia-pacific 11
top Five Countries Contributing To Clinical Trials In Europe 12
top Countries Contributing To Clinical Trials In North America 13
top Five Countries Contributing To Clinical Trials In Middle East And Africa 14
top Five Countries Contributing To Clinical Trials In Central And South America 15
clinical Trials By G7 Countries: Proportion Of Hepatitis C To Infectious Disease Clinical Trials 16
clinical Trials By Phase In G7 Countries 17
clinical Trials In G7 Countries By Trial Status 18
clinical Trials By E7 Countries: Proportion Of Hepatitis C To Infectious Disease Clinical Trials 19
clinical Trials By Phase In E7 Countries 20
clinical Trials In E7 Countries By Trial Status 21
clinical Trials By Phase 22
in Progress Trials By Phase 23
clinical Trials By Trial Status 24
clinical Trials By End Point Status 25
unaccomplished Trials Of Hepatitis C 26
subjects Recruited Over A Period Of Time 41
clinical Trials By Sponsor Type 42
prominent Sponsors 43
top Companies Participating In Hepatitis C Therapeutics Clinical Trials 44
prominent Drugs 46
latest Clinical Trials News On Hepatitis C 47
nov 11, 2014: Gilead Announces Harvoni Study Results In Chronic Hepatitis C Patients With Advanced Liver Disease And Those Who Failed Prior Treatment
47
nov 11, 2014: Gilead Announces Phase 2 Data For Investigational All-oral Regimen Of Sofosbuvir Plus Gs-5816 For The Treatment Of Chronic Hepatitis C 48
nov 11, 2014: Merck Announces Results From Phase 2 Study Of Investigational Chronic Hepatitis C Treatment Grazoprevir/elbasvir In Genotype 1 Infected
Treatment-na
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
Hepatitis C Global Clinical Trials Review, H2, 2014

2. research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Hepatitis C Global Clinical Trials Review, H2, 2014